Clinical trials
Not yet recruiting Phase 4 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
209 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 24 |
| 2025 | 65 |
| 2026 | 106 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 209 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University First Hospital | 12 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 7 |
| Peking Union Medical College Hospital | 6 |
| China National Center for Cardiovascular Diseases | 5 |
| Nanfang Hospital, Southern Medical University | 5 |
| Shanghai Zhongshan Hospital | 5 |
| Chinese SLE Treatment And Research Group | 4 |
| Fudan University | 4 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 4 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 10 |
| Diabetes Mellitus, Type 2 | 7 |
| Breast Neoplasms | 6 |
| Emergence Delirium | 5 |
| Obesity | 5 |
| Agnosia | 4 |
| Hypertension | 4 |
| Stroke | 4 |
| Heart Failure | 3 |
| Overweight | 3 |
Trials
Showing 1 to 25 of 209. Each trial links to its page on Pharma Observatory.
109 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.